Infective endocarditis: past, present and future.
D002512:Cephalothin / Q000627:therapeutic use; D004697:Endocarditis, Bacterial / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology / Q000473:pathology / Q000601:surgery; D004698:Endocarditis, Subacute Bacterial / Q000188:drug therapy / Q000382:microbiology; D004770:Enterovirus / Q000302:isolation & purification; D004917:Erythromycin / Q000627:therapeutic use; D004926:Escherichia coli / Q000302:isolation & purification; D005658:Fungi / Q000302:isolation & purification; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007740:L Forms; D009344:Neisseria gonorrhoeae / Q000302:isolation & purification; D009345:Neisseria meningitidis / Q000302:isolation & purification; D010406:Penicillins / Q000627:therapeutic use; D011183:Postoperative Complications; D011379:Prognosis; D011511:Proteus / Q000302:isolation & purification; D013210:Staphylococcus / Q000302:isolation & purification; D013291:Streptococcus / Q000302:isolation & purification; D013296:Streptococcus pneumoniae / Q000302:isolation & purification
D007166:Immunosuppressive Agents; D010406:Penicillins; D004917:Erythromycin; D002512:Cephalothin